# Trop2-targeting NIR-II Molecular Probe for Breast Cancer Precise Surgery

> **NCT06713681** · — · COMPLETED · sponsor: **Yunnan Cancer Hospital** · enrollment: 59 (actual)

## Conditions studied

- Breast Cancer
- Sentinel Lymph Node
- Margins of Excision

## Interventions

- **DIAGNOSTIC_TEST:** TTP-ICG incubation solution

## Key facts

- **NCT ID:** NCT06713681
- **Lead sponsor:** Yunnan Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-13
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2026-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06713681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06713681, "Trop2-targeting NIR-II Molecular Probe for Breast Cancer Precise Surgery". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06713681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*